Trident Texofab Limited (BOM:540726)
125.05
-6.55 (-4.98%)
At close: Feb 13, 2026
Trident Texofab Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 25.1 | 10.8 | 22.18 | 9.83 | 3.53 |
Depreciation & Amortization | 16.48 | 16.49 | 16.44 | 14.66 | 10.24 |
Other Amortization | 0.02 | 0.12 | 0.13 | 0.98 | 0.44 |
Loss (Gain) From Sale of Assets | - | 0.33 | - | 1.38 | - |
Loss (Gain) From Sale of Investments | -29.84 | -1.02 | -15.81 | -2.28 | -13.65 |
Provision & Write-off of Bad Debts | 8.77 | 7.42 | 6.4 | 9.15 | 7.1 |
Other Operating Activities | 40.41 | 34.29 | 39.88 | 25.39 | 28.25 |
Change in Accounts Receivable | -40.36 | -28 | -35.74 | -5.77 | -38.43 |
Change in Inventory | -24.09 | -29.09 | -33.68 | 7.38 | 21.03 |
Change in Accounts Payable | -24.26 | 11.93 | 61.25 | -43.09 | 2.41 |
Change in Other Net Operating Assets | -109.44 | 3.87 | -2.52 | -3.68 | -1.31 |
Operating Cash Flow | -137.22 | 27.13 | 58.52 | 13.94 | 19.59 |
Operating Cash Flow Growth | - | -53.64% | 319.77% | -28.84% | - |
Capital Expenditures | - | -0.58 | -2.17 | -41.58 | -99.15 |
Sale of Property, Plant & Equipment | - | 0.27 | - | 3.62 | - |
Investment in Securities | 43.25 | -4.69 | -1 | -5.74 | -0.86 |
Other Investing Activities | 1.73 | -0.72 | 6.9 | -0.12 | -1.92 |
Investing Cash Flow | 44.98 | -5.71 | 3.73 | -43.82 | -101.93 |
Short-Term Debt Issued | - | 31.04 | 5.95 | 39.16 | 1.47 |
Long-Term Debt Issued | - | - | - | 14.9 | 91.89 |
Total Debt Issued | - | 31.04 | 5.95 | 54.06 | 93.36 |
Short-Term Debt Repaid | -1.61 | - | - | - | - |
Long-Term Debt Repaid | -105.86 | -13.76 | -34.03 | -2.88 | -2.62 |
Total Debt Repaid | -107.46 | -13.76 | -34.03 | -2.88 | -2.62 |
Net Debt Issued (Repaid) | -107.46 | 17.28 | -28.08 | 51.18 | 90.74 |
Issuance of Common Stock | 244.21 | - | - | - | - |
Other Financing Activities | 229.73 | -37.76 | -33.95 | -21.26 | -8.87 |
Financing Cash Flow | 366.47 | -20.48 | -62.02 | 29.93 | 81.86 |
Miscellaneous Cash Flow Adjustments | -244.22 | 0 | -0 | - | - |
Net Cash Flow | 30.01 | 0.94 | 0.23 | 0.04 | -0.47 |
Free Cash Flow | -137.22 | 26.56 | 56.36 | -27.64 | -79.56 |
Free Cash Flow Growth | - | -52.87% | - | - | - |
Free Cash Flow Margin | -11.24% | 2.67% | 5.85% | -3.28% | -15.93% |
Free Cash Flow Per Share | -11.73 | 2.64 | 5.60 | -2.75 | -7.96 |
Cash Interest Paid | 43.08 | 37.76 | 33.95 | 22.2 | 27.27 |
Cash Income Tax Paid | 3.03 | 1.16 | 1.3 | - | 2.33 |
Levered Free Cash Flow | -187.97 | -15.98 | 18.19 | -61.3 | -87.22 |
Unlevered Free Cash Flow | -159.68 | 9.16 | 52.95 | -36.31 | -67.59 |
Change in Working Capital | -198.15 | -41.3 | -10.7 | -45.16 | -16.31 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.